Efficacy of pembrolizumab versus paclitaxel for gastric cancer: meta-analysis

被引：0
|
作者：
Albert, N. [1 ]
Sabran, M. Zuhriansyah [1 ]
Mokalu, E. Wilhelmina [1 ]
Zebua, A. [1 ]
Rubismo, K. Yogasvara [1 ]
Kurniawan, A. [2 ]
机构：
[1] Univ Pelita Harapan, Fac Med, Tangerang, Indonesia
[2] Univ Pelita Harapan, Dept Internal Med, Fac Med, Tangerang, Indonesia
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.381
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10-4
引用
收藏
页码：S1369 / S1369
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of nab-paclitaxel in metastatic gastric cancer: a meta-analysis
    Ahmad, Suhana
    Lambuk, Lidawani
    Ahmed, Naveed
    Mussa, Ali
    Tee, Vincent
    Idris, Ros Akmal Mohd
    Sahran, Nur Fazimah
    Chan, Yean Yean
    Hassan, Rosline
    Lee, Yeong Yeh
    Mohamud, Rohimah
    NANOMEDICINE, 2023, 18 (24) : 1733 - 1744
  • [2] Meta-Analysis of the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced Gastric Cancer and Gastroesophageal Junction Cancer
    Yang, Jingyun
    Luo, Weisheng
    Ma, Xiaocong
    Cui, Yinhang
    Xie, Jiacheng
    Pan, Chengzhen
    Chen, Ziyao
    Yang, Shuang
    CHEMOTHERAPY, 2025, 70 (01)
  • [3] Efficacy and safety of pembrolizumab in advanced gastric and gastroesophageal junction cancer: a systematic review and meta-analysis
    Ji, Xiaoying
    Wang, Guoping
    Pan, Dandan
    Xu, Shanxia
    Lei, Xinming
    BMC GASTROENTEROLOGY, 2025, 25 (01)
  • [4] Efficacy of Chemoimmunotherapy versus Chemotherapy for Gastric Cancer: A Meta-Analysis of Survival Outcomes
    Xie, Juan
    Chen, Lin
    Liu, Qing
    Li, Xi-Tai
    Lei, Xiao-Yong
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (18) : 2649 - 2660
  • [5] Comparative efficacy and safety of eribulin versus paclitaxel in breast cancer: a systematic review and meta-analysis
    Zhang, Jialin
    Su, Jingyang
    Ni, Cui
    Lu, Jinhua
    FUTURE ONCOLOGY, 2024, 20 (40) : 3507 - 3517
  • [6] RETRACTED: A Meta-Analysis of the Efficacy of Albumin Paclitaxel versus Docetaxel in the Treatment of Breast Cancer (Retracted Article)
    Xu, Huixin
    Li, Yue
    Guo, Jianming
    Sui, Yuan
    Chen, Baihui
    Li, Dalin
    Jiang, Jiakang
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [7] Efficacy and Safety of Pembrolizumab in the Treatment of Esophageal and Gastroesophageal Junction Cancer: A Meta-Analysis
    Li, Siwen
    Chen, Guang
    You, Shuang
    Chen, Xuezhang
    Liu, Xiaoli
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (10): : 5115 - 5127
  • [8] Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
    Zhang, Xue
    Yin, Wen-Jie
    Zhang, Ai-Li
    Zhang, Xiao-Xiao
    Ding, Li-Juan
    Zhang, Jiao
    He, Shu-Ting
    Yan, Jie-Ping
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 44 (01)
  • [9] Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
    Zhang, Qi
    Huo, Geng-wei
    Zhang, Hong-zhen
    Song, Ying
    OPEN MEDICINE, 2020, 15 (01): : 447 - 456
  • [10] The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.
    Fuchs, Charles S.
    Ozguroglu, Mustafa
    Bang, Yung-Jue
    Di Bartolomeo, Maria
    Mandala, Mario
    Ryu, Min-hee
    Vivaldi, Caterina
    Olesinski, Tomasz
    Caglevic, Christian
    Chung, Hyun Cheol
    Muro, Kei
    Van Cutsem, Eric
    Kobie, Julie
    Cristescu, Razvan
    Aurora-Garg, Deepti
    Lu, Jia
    Shih, Chie-Schin
    Adelberg, David
    Cao, Z. Alexander
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345